🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST

Edwards Lifesciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,0211,0744,1751,4021,5221,503
Depreciation & Amortization
171.2156.6143.2122139.6134.8
Loss (Gain) From Sale of Assets
-33.9-33.9-3,348---
Asset Writedown & Restructuring Costs
220.240--55.14
Loss (Gain) From Sale of Investments
140.3146.9-55-51.5-36.8
Stock-Based Compensation
172.8158.1162.3139.4126.8109.3
Other Operating Activities
106-100.6-287.3-264.6-255.3-127.6
Change in Accounts Receivable
-115.6-23121.2-141.2-84.1-91.1
Change in Inventory
-38.750.7-256.1-289-213.419
Change in Accounts Payable
12.5395.189.5146-21.4195.2
Change in Income Taxes
155.3-141.8-186.7-5.8-5.662
Change in Other Net Operating Assets
-94.5-126.4-27.2-236.3-96.9-39.8
Operating Cash Flow
1,7171,595542.3895.81,2181,732
Operating Cash Flow Growth
68.85%194.16%-39.46%-26.46%-29.67%64.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-292.8-260.2-252.4-253-244.6-325.8
Cash Acquisitions
-33.7--1,062-95.2--
Divestitures
42.542.53,927---
Sale (Purchase) of Intangibles
---30-13.3-20.2-4
Investment in Securities
-371.9-321.8-148.5624.5689.8-1,350
Other Investing Activities
-84.8-173.4-121.8-89.2-172.7-42.6
Investing Cash Flow
-740.7-712.92,313173.8252.3-1,723

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----5.2
Long-Term Debt Repaid
------7
Net Debt Issued (Repaid)
------1.8
Issuance of Common Stock
191.5174.1179.5169.9146.4158.6
Repurchase of Common Stock
-754.6-893.4-1,159-879.6-1,727-512.8
Other Financing Activities
-0.6-237.5-3.1-1.3-3.8-0.3
Financing Cash Flow
-563.7-956.8-983-711-1,585-356.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
5.1-44.838.616.819.213.9
Net Cash Flow
417.6-119.31,911375.4-94.8-332.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4241,335289.9642.8973.61,406
Free Cash Flow Growth
77.08%360.50%-54.90%-33.98%-30.77%117.26%
Free Cash Flow Margin
21.34%22.00%5.33%12.83%21.81%26.88%
Free Cash Flow Per Share
2.462.280.481.051.562.23
Levered Free Cash Flow
1,1451,1701,339566.93776.731,009
Unlevered Free Cash Flow
1,1581,1821,351577.93788.731,020

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.220.219.619.919.320.2
Cash Income Tax Paid
217.7490.41,166444.9466.7182.5
Change in Working Capital
-81154.6-259.3-526.3-421.4145.3
SEC Filings: 10-K · 10-Q